366PD - Oncolytic herpesvirus therapy for mesothelioma: A phase I/IIa trial of intrapleural administration of HSV1716 (NCT01721018)
Autor: | Danson, S. 1, Woll, P. 2, Edwards, J. 3, Blyth, K. 4, Fisher, P. 2, Roman, J. 5, Simpson, K. 5, Spavin, R. 5, Learmonth, K. 5, Conner, J. 5 |
---|---|
Zdroj: | In Annals of Oncology September 2017 28 Supplement 5:v122-v122 |
Databáze: | ScienceDirect |
Externí odkaz: |